Sirenengesänge. Neun Bamberger Vorträge zu Libretto und Musiktheater

Im Sommersemester 2015 am Institut für Romanistik der Universität Bamberg eine Reihe von acht Vorträgen zum (Opern- und Operetten)Libretto und zum Musiktheater statt. Behandelt wurden die Unterschiede zwischen deutscher und französischer Operette; Exotismus im (italienischen und frnazösischen) Musiktheater des 17. und 18. Jahrhunderts; Offenbach und sein Werk in der zeitgenössischen Karikatur; neue Formen des Erzählens im Musiktheater der Gegenwart; die Künstleroper; Probleme bei der Übersetzung von Barocklibretti; Mozarts Librettisten; das Verhältnis von Text, Musik und Inszenierung in Musiktheater und Chanson. Am Ende steht die Abschiedsvorlesung ders Herausgebers zu den Sirenen in Literatur und Musiktheater.During the summer half 2016, a series of 6 lectures about the libretto in opera and operetta took place at the Institut für Romanistik of Bamberg Universtiy. They dealt with the differences between French and German operetta; exoticism in the opera of the 17th / 18th centuries; Jacques Offenbach and his theatre in contemporary caricatures; new types of narrative in the opera today; the "Künstleroper"; how to translate Italian opera librettos of the 17th century; Mozart's librettists; the interrelations between text, music, and scene in opera and song. The volume is closed by the farewell lecture of the editor Albert Gier about the sirens in literature and opera

Göttliche, menschliche und teuflische Komödien - Europäische Welttheater-Entwürfe im 19. und 20. Jahrhundert

Theater kann nicht nur Welt abbilden, sondern auch die Welt selbst als ein Theater darstellen, in dem Gott (oder das Schicksal) die Rollen verteilt und Regie führt. So wurde 'Welttheater' im europäischen Barock aufgefasst. Seit der Aufklärung schwindet der Glaube an den göttlichen Regisseur, die Denkfigur 'Welttheater' behält aber auch im 19. und 20. Jahrhundert ihre Attraktivität. Im Rahmen einer Ringvorlesung an der Fakultät Geistes- und Kulturwissenschaften der Otto-Friedrich-Universität Bamberg im Wintersemester 2009/2010 wurden dreizehn Beispiele modernen Welttheaters aus Sprech- und Musiktheater Frankreichs, Italiens, Ungarns, Rußlands und Deutschlands vorgestellt (mit Ausblicken zu Film und Fernsehen), von Goethes Faust über Wagners Ring des Nibelungen, Imre Madàchs Tragödie des Menschen, Hofmannsthals Großes Salzburger Welttheater oder Paul Claudels Seidenen Schuh bis hin zu Tankred Dorsts Merlin und Karlheinz Stockausens LICHT-Zyklus. Den Abschluss bildet ein Werkstattgespräch mit dem Komponisten Peter Eötvös und seinem Librettisten Albert Ostermaier, deren Oper Die Tragödie des Teufels im Februar 2010 in München uraufgeführt wurde

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Background: The impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on postoperative recovery needs to be understood to inform clinical decision making during and after the COVID-19 pandemic. This study reports 30-day mortality and pulmonary complication rates in patients with perioperative SARS-CoV-2 infection. Methods: This international, multicentre, cohort study at 235 hospitals in 24 countries included all patients undergoing surgery who had SARS-CoV-2 infection confirmed within 7 days before or 30 days after surgery. The primary outcome measure was 30-day postoperative mortality and was assessed in all enrolled patients. The main secondary outcome measure was pulmonary complications, defined as pneumonia, acute respiratory distress syndrome, or unexpected postoperative ventilation. Findings: This analysis includes 1128 patients who had surgery between Jan 1 and March 31, 2020, of whom 835 (74·0%) had emergency surgery and 280 (24·8%) had elective surgery. SARS-CoV-2 infection was confirmed preoperatively in 294 (26·1%) patients. 30-day mortality was 23·8% (268 of 1128). Pulmonary complications occurred in 577 (51·2%) of 1128 patients; 30-day mortality in these patients was 38·0% (219 of 577), accounting for 81·7% (219 of 268) of all deaths. In adjusted analyses, 30-day mortality was associated with male sex (odds ratio 1·75 [95% CI 1·28–2·40], p\textless0·0001), age 70 years or older versus younger than 70 years (2·30 [1·65–3·22], p\textless0·0001), American Society of Anesthesiologists grades 3–5 versus grades 1–2 (2·35 [1·57–3·53], p\textless0·0001), malignant versus benign or obstetric diagnosis (1·55 [1·01–2·39], p=0·046), emergency versus elective surgery (1·67 [1·06–2·63], p=0·026), and major versus minor surgery (1·52 [1·01–2·31], p=0·047). Interpretation: Postoperative pulmonary complications occur in half of patients with perioperative SARS-CoV-2 infection and are associated with high mortality. Thresholds for surgery during the COVID-19 pandemic should be higher than during normal practice, particularly in men aged 70 years and older. Consideration should be given for postponing non-urgent procedures and promoting non-operative treatment to delay or avoid the need for surgery. Funding: National Institute for Health Research (NIHR), Association of Coloproctology of Great Britain and Ireland, Bowel and Cancer Research, Bowel Disease Research Foundation, Association of Upper Gastrointestinal Surgeons, British Association of Surgical Oncology, British Gynaecological Cancer Society, European Society of Coloproctology, NIHR Academy, Sarcoma UK, Vascular Society for Great Britain and Ireland, and Yorkshire Cancer Research

Retrospective evaluation of whole exome and genome mutation calls in 746 cancer samples

Funder: NCI U24CA211006Abstract: The Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) curated consensus somatic mutation calls using whole exome sequencing (WES) and whole genome sequencing (WGS), respectively. Here, as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium, which aggregated whole genome sequencing data from 2,658 cancers across 38 tumour types, we compare WES and WGS side-by-side from 746 TCGA samples, finding that ~80% of mutations overlap in covered exonic regions. We estimate that low variant allele fraction (VAF < 15%) and clonal heterogeneity contribute up to 68% of private WGS mutations and 71% of private WES mutations. We observe that ~30% of private WGS mutations trace to mutations identified by a single variant caller in WES consensus efforts. WGS captures both ~50% more variation in exonic regions and un-observed mutations in loci with variable GC-content. Together, our analysis highlights technological divergences between two reproducible somatic variant detection efforts

Sex differences in oncogenic mutational processes

Funder: Canadian Network for Research and Innovation in Machining Technology, Natural Sciences and Engineering Research Council of Canada (NSERC Canadian Network for Research and Innovation in Machining Technology); doi: https://doi.org/10.13039/501100002790Funder: Genome Canada (Génome Canada); doi: https://doi.org/10.13039/100008762Funder: Canada Foundation for Innovation (Fondation canadienne pour l'innovation); doi: https://doi.org/10.13039/501100000196Funder: Terry Fox Research Institute (Institut de Recherche Terry Fox); doi: https://doi.org/10.13039/501100004376Abstract: Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, and in most cancers outside the sex organs. Efforts to link these clinical differences to specific molecular features have focused on somatic mutations within the coding regions of the genome. Here we report a pan-cancer analysis of sex differences in whole genomes of 1983 tumours of 28 subtypes as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium. We both confirm the results of exome studies, and also uncover previously undescribed sex differences. These include sex-biases in coding and non-coding cancer drivers, mutation prevalence and strikingly, in mutational signatures related to underlying mutational processes. These results underline the pervasiveness of molecular sex differences and strengthen the call for increased consideration of sex in molecular cancer research

Sex differences in oncogenic mutational processes

Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, and in most cancers outside the sex organs. Efforts to link these clinical differences to specific molecular features have focused on somatic mutations within the coding regions of the genome. Here we report a pan-cancer analysis of sex differences in whole genomes of 1983 tumours of 28 subtypes as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium. We both confirm the results of exome studies, and also uncover previously undescribed sex differences. These include sex-biases in coding and non-coding cancer drivers, mutation prevalence and strikingly, in mutational signatures related to underlying mutational processes. These results underline the pervasiveness of molecular sex differences and strengthen the call for increased consideration of sex in molecular cancer research.Sex differences have been observed in multiple facets of cancer epidemiology, treatment and biology, and in most cancers outside the sex organs. Efforts to link these clinical differences to specific molecular features have focused on somatic mutations within the coding regions of the genome. Here we report a pan-cancer analysis of sex differences in whole genomes of 1983 tumours of 28 subtypes as part of the ICGC/TCGA Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium. We both confirm the results of exome studies, and also uncover previously undescribed sex differences. These include sex-biases in coding and non-coding cancer drivers, mutation prevalence and strikingly, in mutational signatures related to underlying mutational processes. These results underline the pervasiveness of molecular sex differences and strengthen the call for increased consideration of sex in molecular cancer research.Peer reviewe